The interference between SARS-COV-2 and Alzheimer's disease:Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic
Description
Coronavirus disease 2019 (COVID-19) has infected over 700 million people, with up to 30% developing neurological manifestations, including dementias. However, there is a lack of understanding of common molecular brain markers causing Alzheimer's